These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 7822782

  • 1. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C, van Endert P, Koch N.
    J Immunol; 1995 Feb 01; 154(3):1048-56. PubMed ID: 7822782
    [Abstract] [Full Text] [Related]

  • 2. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Busch R, Vturina IY, Drexler J, Momburg F, Hämmerling GJ.
    Eur J Immunol; 1995 Jan 01; 25(1):48-53. PubMed ID: 7843252
    [Abstract] [Full Text] [Related]

  • 3. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L, Kovats S, Eastman S, Rudensky AY.
    J Immunol; 1996 Mar 15; 156(6):2196 - 2204. PubMed ID: 8690909
    [Abstract] [Full Text] [Related]

  • 4. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO, LaVaute T, Pinet V, Jaraquemada D.
    J Immunol; 1994 Aug 15; 153(4):1487-94. PubMed ID: 8046228
    [Abstract] [Full Text] [Related]

  • 5. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
    Schafer PH, Green JM, Malapati S, Gu L, Pierce SK.
    J Immunol; 1996 Dec 15; 157(12):5487-95. PubMed ID: 8955198
    [Abstract] [Full Text] [Related]

  • 6. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J, König A, Koch N.
    Int Immunol; 2007 Jan 15; 19(1):31-9. PubMed ID: 17105964
    [Abstract] [Full Text] [Related]

  • 7. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
    Lamb CA, Cresswell P.
    J Immunol; 1992 Jun 01; 148(11):3478-82. PubMed ID: 1588042
    [Abstract] [Full Text] [Related]

  • 8. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.
    Théry C, Brachet V, Regnault A, Rescigno M, Ricciardi-Castagnoli P, Bonnerot C, Amigorena S.
    J Immunol; 1998 Sep 01; 161(5):2106-13. PubMed ID: 9725201
    [Abstract] [Full Text] [Related]

  • 9. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers.
    Hmama Z, Gabathuler R, Jefferies WA, de Jong G, Reiner NE.
    J Immunol; 1998 Nov 01; 161(9):4882-93. PubMed ID: 9794422
    [Abstract] [Full Text] [Related]

  • 10. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
    Monji T, McCormack AL, Yates JR, Pious D.
    J Immunol; 1994 Nov 15; 153(10):4468-77. PubMed ID: 7525705
    [Abstract] [Full Text] [Related]

  • 11. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S.
    Eur J Immunol; 1993 Sep 15; 23(9):2100-8. PubMed ID: 8370392
    [Abstract] [Full Text] [Related]

  • 12. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
    Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P.
    Nature; 1992 Dec 03; 360(6403):474-7. PubMed ID: 1448172
    [Abstract] [Full Text] [Related]

  • 13. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S, Humphreys RE.
    Eur J Immunol; 1995 Jun 03; 25(6):1693-702. PubMed ID: 7614997
    [Abstract] [Full Text] [Related]

  • 14. Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74).
    Koch N, Moldenhauer G, Hofmann WJ, Möller P.
    J Immunol; 1991 Oct 15; 147(8):2643-51. PubMed ID: 1918985
    [Abstract] [Full Text] [Related]

  • 15. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C, Schwenk F, Koch N, Möller P.
    Immunology; 1995 Feb 15; 84(2):177-82. PubMed ID: 7750992
    [Abstract] [Full Text] [Related]

  • 16. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
    Agrawal B, Fraga E, Kane K, Singh B.
    J Immunol; 1994 Feb 01; 152(3):965-75. PubMed ID: 8301149
    [Abstract] [Full Text] [Related]

  • 17. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA, Chaturvedi P, Lee-Chan EC, Rider BJ, Singh B.
    J Immunol; 1996 Jun 01; 156(11):4232-9. PubMed ID: 8666792
    [Abstract] [Full Text] [Related]

  • 18. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
    Teyton L, O'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, Peterson PA.
    Nature; 1990 Nov 01; 348(6296):39-44. PubMed ID: 2234057
    [Abstract] [Full Text] [Related]

  • 19. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL, Smith KD, Lutz CT.
    J Immunol; 1996 Nov 15; 157(10):4503-10. PubMed ID: 8906828
    [Abstract] [Full Text] [Related]

  • 20. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
    Khalil H, Brunet A, Thibodeau J.
    J Cell Sci; 2005 Oct 15; 118(Pt 20):4679-87. PubMed ID: 16188937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.